Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H23N3O3S |
Molecular Weight | 325.426 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2N=CN3CCCCCC3)C(O)=O
InChI
InChIKey=BWWVAEOLVKTZFQ-ISVUSNJMSA-N
InChI=1S/C15H23N3O3S/c1-15(2)11(14(20)21)18-12(19)10(13(18)22-15)16-9-17-7-5-3-4-6-8-17/h9-11,13H,3-8H2,1-2H3,(H,20,21)/b16-9+/t10-,11+,13-/m1/s1
Molecular Formula | C15H23N3O3S |
Molecular Weight | 325.426 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:36:06 UTC 2023
by
admin
on
Fri Dec 15 15:36:06 UTC 2023
|
Record UNII |
V10579P3QZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1500
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
||
|
WHO-ATC |
J01CA11
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
||
|
WHO-VATC |
QJ01CA11
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
32887-01-7
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
MECILLINAM
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
C65229
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
3494
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
51213
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
100000081775
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
m1653
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB08675MIG
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
1648
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
DB01163
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
D000560
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
51208
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
CHEMBL530
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
626
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | RxNorm | ||
|
V10579P3QZ
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
36273
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
DTXSID3022584
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY | |||
|
251-277-1
Created by
admin on Fri Dec 15 15:36:06 UTC 2023 , Edited by admin on Fri Dec 15 15:36:06 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of total dose; in 6hr pooled urine after single oral administration of Pivmecillinam (500mg as Amdinocillin); two adult male
IN-VIVO
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
IN-VIVO
URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Unit: percent of total dose; in 6hr pooled urine after single oral administration of Pivmecillinam (500mg as Amdinocillin); two adult male
IN-VIVO
URINE
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |